FDA Inspection
U.S. Investigational Review Board Inc.U.S. Investigational Review Board Inc. – FDA Inspection, Jun 6, 2022
Record Details
This FDA Inspection record concerns U.S. Investigational Review Board Inc., with an inspection on June 6, 2022, covering biologics.
- Inspection Date
- June 6, 2022
- Product Type
- Biologics
View Company Profile
ID · 8c9d4fef-ad4f-45ee-b3cf-ee653f457c84
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1171335
- FDA center
- Biologics
- Project area
- Bioresearch Monitoring
FDA Citations
4- 21 CFR 56.115(a)(2)Minutes of IRB meetings
- 21 CFR 56.106(e)Changes re: review new products or discontinue reviewing
- 21 CFR 56.110(b)(1)No more than minimal risk
- 21 CFR 56.110(c)Method to keep members advised
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.